03.01.2013 Views

IMS Company Profiles - Report Buyer

IMS Company Profiles - Report Buyer

IMS Company Profiles - Report Buyer

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

<strong>IMS</strong> COM PANY PRO FILES TAKEDA<br />

Product Class Date Terms of Agreement<br />

Spectracef (cefditoren<br />

pivoxil)<br />

J 1997 TAP licensed-in exclusive rights to cefditoren pivoxil in<br />

North America from originator Meiji Seika. In 1999,<br />

Abbott obtained exclusive rights in Latin America, plus<br />

co-marketing rights in Europe (with Gruenenthal) and an<br />

option for the product in Asian countries outside Japan.<br />

However, Takeda and Abbott have now withdrawn from<br />

this deal.<br />

Benet (risedronic acid) M 1992 Originally developed by Procter & Gamble and licensed to<br />

Ajinomoto for Japan. It was then co-developed with<br />

sub-licensees Takeda and Aventis, following an<br />

agreement between P&G and Aventis to market the<br />

product worldwide.<br />

Basen (voglibose) A N/A Licensed out to Cheil for South Korea.<br />

Takepron (lansoprazole) A N/A Marketed by TAP jv with Abbott in the US, and by Takeda<br />

Pharma in German-speaking markets. Licensed out to<br />

Abbott for Canada and Latin America and to Boehringer<br />

Ingelheim and Roemmers for some Latin American<br />

countries. Almirall Prodesfarma for Spain. Wyeth for the<br />

UK, Denmark, Australia, Sweden, Norway and Pakistan.<br />

Aventis for France, Germany, the NL, Belgium, Africa and<br />

the Middle East. To Orion for Finland. To Han Il for South<br />

Korea.<br />

Blopress (candesartan<br />

cilexetil)/Blopress Comp<br />

(candesartan<br />

cilexetil/hydrochlorothiazi<br />

de)<br />

Uprima/Ixense (sublingual<br />

apomorphine)<br />

Adecut/Cupressin<br />

(delapril)<br />

C N/A Licensed out to AstraZeneca for exclusive marketing in<br />

Belgium, Denmark, Finland, the Netherlands, Norway,<br />

New Zealand, Australia, and South Africa, and<br />

co-marketing in the rest of the world outside Japan.<br />

Licensed out to Teva for Israel, Orion for Ireland, Almirall<br />

Prodesfarma for Spain, Abbott for co-marketing in<br />

Mexico, Brazil, and Argentina with AstraZeneca, and in<br />

Chile with Saval.<br />

G N/A Takeda has licensed-out the product to TAP for the USA.<br />

TAP has in turn licensed it out to Abbott for other<br />

markets. TAP holds exclusive worldwide rights to<br />

apomorphine for the treatment of Parkinson’s Disease.<br />

C N/A Licensed-out to Chiesi for Italy.<br />

Acel-Imune (DTP vaccine) J N/A Licensed out to Lederle-Praxis Biologicals (Wyeth) for<br />

markets outside Japan.<br />

© 2009 <strong>IMS</strong> Health In cor po rated or its af fil i ates Page 93

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!